Promoting Dialogue and Understanding Between Korea and the United States
Stay Informed
Register now for the KEI mailing list and be the first to know.
Search All Site Content
Total Index: 6332 publications.
Subscribe to our Mailing List!
Sign up for our mailing list to keep up to date on all the latest developments.
Korea Economic Institute of America Presents:
South Korea as a Global Vaccine Hub
Read Event DescriptionEvent Date
October 27th 3:00pm - 4:00pm ET
Event Location
Livestream via YouTube
Key Points
Here are some takeaways from the event:
- The scramble to adopt countermeasures to the Covid-19 pandemic revealed significant challenges to vaccine access not just for advanced countries like South Korea but especially for low- and middle-income countries (LMICs).
- Despite the prevalence of the blanket term “vaccine hub” among the public and policymakers, the authors identify two distinct types of vaccine hub: the “WHO vaccine hub” and “global vaccine hub,” both of which aim to address problems with vaccine equity globally.
- By becoming a global vaccine hub, South Korea seeks to establish itself as a key center of vaccine development, manufacturing, and training, allowing the country to play a crucial role in bolstering global public health capacities, particularly in LMICs.
Event Description
Early in the pandemic, South Korea drew widespread praise for the speed and efficiency of its response to slowing the spread of the virus and saving lives. However, despite this initial success, South Korea faced vaccine nationalism and other access challenges in its effort to secure Covid-19 vaccines. Spurred by these challenges, South Korea established a national strategic policy to become a global vaccine hub, not only to meet the current and future public health needs of its own population but also to assist low- and middle-income countries (LMICs) facing even starker obstacles in accessing safe and effective vaccines.
Please join KEI for a discussion with the Thomas Byrne, Claire Callahan, Irene Kyoung, and Salome Da Silva Duarte Lepez about how global vaccine access and equity was hindered by the shortcomings of national and bilateral vaccine diplomacy and multilateral mechanisms during the Covid-19 pandemic, and how South Korea’s demonstrated capabilities to rise as global vaccine development, manufacturing and training hub will help bolster global public health capacities in the future.